Lai Wang - President, Global Head of R&D at BeOne Medicines Ltd.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Global Head of R&D
Issuer Symbol
ONC on Nasdaq, BEIGF on OTC
All Insider Reports
All Insider Reports

Lai Wang - trading volume in the past year for BeOne Medicines Ltd.

Holdings reported by Lai Wang for BeOne Medicines Ltd.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 1,451,424 $481,001,913 $331.40 31 Dec 2025 Direct
Ordinary Shares 601,965 $199,491,201 $331.40 31 Dec 2025 Indirect
American Depositary Shares 0 $0 $260.00 23 Jun 2025 Direct
American Depositary Shares 0 $0 $350.06 09 Sep 2025 Indirect
Share Option (Right to Buy) 162,565 10 Jun 2025 Direct Ordinary Shares
RMB Shares 0 31 Dec 2025 Indirect

Transactions reported by Lai Wang for BeOne Medicines Ltd.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.